As part of its commitment with innovation and entrepreneurship, the Biotechnology Business Institute and Richi Entrepreneurs present the first Childhood Cancer Innovation Award, a charity event in favor of pediatric investigation.

The Summer Charity Cocktail will take place next June 29th, in an unique spot of the coast of Barcelona, which will gather together family, friends, colleagues and professionals of the biopharmaceutical sector to discover the winner between the three projects preselected by an expert jury. The winner company will have the opportunity to travel and meet the city of Boston, owner of one of the most promising innovation hubs in Life Sciences of the world.

The founder of Richi Foundation, Ricard García, currently living in the United States, has expressed his support to the Summer Charity Cocktail and will be present during the event, where García will be part of the expert jury. The candidatures of the three finalist startups from the biotechnology area, Iproteos, BIOGENERA SpA and Parpipred (VHIO), will be valued by an expert jury that will evaluate the innovative nature of the projects and the potential impact in the run against pediatric cancer.

Richi Entrepreneurs, the immersion program of Richi Cildhood Cancer Foundation, is an initiative whose mission is to boost startups from all over the world that have the potential to generate a positive impact on society in the health space, by connecting them with Boston’s innovation key players -industry, investors, hospitals, accelerators, academia and other potential partners- and helping them make the most out of this unique innovation ecosystem.

“The agreement with Richi Foundation is part of one of the main objectives of the Institute. From the academic programs, the Biotechnology Business Institute promotes entrepreneurship and the development of innovative ideas in the biotechnology and biomedicine areas, as well as future leaders in Pharmaceutical and Biotechnology sector”, has expressed Juan R. García, Managing Partner of the Institute.

The award ceremony of the Childhood Cancer Innovation Award is celebrated together with the 5th anniversary of the Biotechnology Business Institute. The business school reaches five years of continuous education of professionals and future leaders of the biotechnology and pharmaceutical sector.

“This event is a great example of how to leverage a special occasion - the 5th anniversary of IEB - to give back to society”, has explained Ernest Lara, Executive Director of Richi Entrepreneurs. “We truly thank the Biotechnology Business Institute for giving us the opportunity of connecting our activity at Richi Entrepreneurs with the original mission of the Richi Childhood Cancer Foundation, by supporting the startup with the highest potential for impact in childhood cancer”. 

Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filter by category